chevron_leftBack
As of 24 April 2025, CBD of Denver Inc. has a market cap of $892.56K USD, ranking #39023 globally and #418 in Germany. It ranks #3967 in the Healthcare sector, and #841 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$892.56KUSD
Revenue (TTM)
$42.5KUSD
EBITDA (TTM)
-$295.93KUSD
Net Income (TTM)
-$503.32KUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -33% | -50% | -71% | -67% | -92% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CBDD
CBD Of Denver Inc
ISIN: US12482B1070
Shares Out.:
Shares Outstanding:
8.926B1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0001 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CBD of Denver Inc.
CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Centennial, Colorado. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.
